Global Gabapentin Market Research Report 2025(Status and Outlook)

August 2025 | 153 pages | ID: GF1ECB03E6D6EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

The global Gabapentin market size was estimated at USD 1538.62 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 0.02% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Gabapentin market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Gabapentin market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gabapentin market.

Global Gabapentin Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike

Market Segmentation (by Type)

Capsule
Tablet

Market Segmentation (by Application)

Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Gabapentin Market
  • Overview of the regional outlook of the Gabapentin Market:
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline


Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gabapentin Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Gabapentin, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Gabapentin
1.2 Key Market Segments
  1.2.1 Gabapentin Segment by Type
  1.2.2 Gabapentin Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GABAPENTIN MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Gabapentin Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Gabapentin Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GABAPENTIN MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Gabapentin Product Life Cycle
3.3 Global Gabapentin Sales by Manufacturers (2020-2025)
3.4 Global Gabapentin Revenue Market Share by Manufacturers (2020-2025)
3.5 Gabapentin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gabapentin Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gabapentin Market Competitive Situation and Trends
  3.8.1 Gabapentin Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Gabapentin Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 GABAPENTIN INDUSTRY CHAIN ANALYSIS

4.1 Gabapentin Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF GABAPENTIN MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Gabapentin Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Gabapentin Market
5.7 ESG Ratings of Leading Companies

6 GABAPENTIN MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gabapentin Sales Market Share by Type (2020-2025)
6.3 Global Gabapentin Market Size Market Share by Type (2020-2025)
6.4 Global Gabapentin Price by Type (2020-2025)

7 GABAPENTIN MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gabapentin Market Sales by Application (2020-2025)
7.3 Global Gabapentin Market Size (M USD) by Application (2020-2025)
7.4 Global Gabapentin Sales Growth Rate by Application (2020-2025)

8 GABAPENTIN MARKET SALES BY REGION

8.1 Global Gabapentin Sales by Region
  8.1.1 Global Gabapentin Sales by Region
  8.1.2 Global Gabapentin Sales Market Share by Region
8.2 Global Gabapentin Market Size by Region
  8.2.1 Global Gabapentin Market Size by Region
  8.2.2 Global Gabapentin Market Size Market Share by Region
8.3 North America
  8.3.1 North America Gabapentin Sales by Country
  8.3.2 North America Gabapentin Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Gabapentin Sales by Country
  8.4.2 Europe Gabapentin Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Gabapentin Sales by Region
  8.5.2 Asia Pacific Gabapentin Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Gabapentin Sales by Country
  8.6.2 South America Gabapentin Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Gabapentin Sales by Region
  8.7.2 Middle East and Africa Gabapentin Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 GABAPENTIN MARKET PRODUCTION BY REGION

9.1 Global Production of Gabapentin by Region(2020-2025)
9.2 Global Gabapentin Revenue Market Share by Region (2020-2025)
9.3 Global Gabapentin Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gabapentin Production
  9.4.1 North America Gabapentin Production Growth Rate (2020-2025)
  9.4.2 North America Gabapentin Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gabapentin Production
  9.5.1 Europe Gabapentin Production Growth Rate (2020-2025)
  9.5.2 Europe Gabapentin Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gabapentin Production (2020-2025)
  9.6.1 Japan Gabapentin Production Growth Rate (2020-2025)
  9.6.2 Japan Gabapentin Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gabapentin Production (2020-2025)
  9.7.1 China Gabapentin Production Growth Rate (2020-2025)
  9.7.2 China Gabapentin Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Pfizer
  10.1.1 Pfizer Basic Information
  10.1.2 Pfizer Gabapentin Product Overview
  10.1.3 Pfizer Gabapentin Product Market Performance
  10.1.4 Pfizer Business Overview
  10.1.5 Pfizer SWOT Analysis
  10.1.6 Pfizer Recent Developments
10.2 Assertio Therapeutics
  10.2.1 Assertio Therapeutics Basic Information
  10.2.2 Assertio Therapeutics Gabapentin Product Overview
  10.2.3 Assertio Therapeutics Gabapentin Product Market Performance
  10.2.4 Assertio Therapeutics Business Overview
  10.2.5 Assertio Therapeutics SWOT Analysis
  10.2.6 Assertio Therapeutics Recent Developments
10.3 TEVA
  10.3.1 TEVA Basic Information
  10.3.2 TEVA Gabapentin Product Overview
  10.3.3 TEVA Gabapentin Product Market Performance
  10.3.4 TEVA Business Overview
  10.3.5 TEVA SWOT Analysis
  10.3.6 TEVA Recent Developments
10.4 Mylan
  10.4.1 Mylan Basic Information
  10.4.2 Mylan Gabapentin Product Overview
  10.4.3 Mylan Gabapentin Product Market Performance
  10.4.4 Mylan Business Overview
  10.4.5 Mylan Recent Developments
10.5 Arbor Pharma
  10.5.1 Arbor Pharma Basic Information
  10.5.2 Arbor Pharma Gabapentin Product Overview
  10.5.3 Arbor Pharma Gabapentin Product Market Performance
  10.5.4 Arbor Pharma Business Overview
  10.5.5 Arbor Pharma Recent Developments
10.6 Novartis
  10.6.1 Novartis Basic Information
  10.6.2 Novartis Gabapentin Product Overview
  10.6.3 Novartis Gabapentin Product Market Performance
  10.6.4 Novartis Business Overview
  10.6.5 Novartis Recent Developments
10.7 Apotex
  10.7.1 Apotex Basic Information
  10.7.2 Apotex Gabapentin Product Overview
  10.7.3 Apotex Gabapentin Product Market Performance
  10.7.4 Apotex Business Overview
  10.7.5 Apotex Recent Developments
10.8 Sun Pharmaceutical
  10.8.1 Sun Pharmaceutical Basic Information
  10.8.2 Sun Pharmaceutical Gabapentin Product Overview
  10.8.3 Sun Pharmaceutical Gabapentin Product Market Performance
  10.8.4 Sun Pharmaceutical Business Overview
  10.8.5 Sun Pharmaceutical Recent Developments
10.9 Aurobindo Pharma
  10.9.1 Aurobindo Pharma Basic Information
  10.9.2 Aurobindo Pharma Gabapentin Product Overview
  10.9.3 Aurobindo Pharma Gabapentin Product Market Performance
  10.9.4 Aurobindo Pharma Business Overview
  10.9.5 Aurobindo Pharma Recent Developments
10.10 Intas
  10.10.1 Intas Basic Information
  10.10.2 Intas Gabapentin Product Overview
  10.10.3 Intas Gabapentin Product Market Performance
  10.10.4 Intas Business Overview
  10.10.5 Intas Recent Developments
10.11 Amneal
  10.11.1 Amneal Basic Information
  10.11.2 Amneal Gabapentin Product Overview
  10.11.3 Amneal Gabapentin Product Market Performance
  10.11.4 Amneal Business Overview
  10.11.5 Amneal Recent Developments
10.12 Marksans Pharma
  10.12.1 Marksans Pharma Basic Information
  10.12.2 Marksans Pharma Gabapentin Product Overview
  10.12.3 Marksans Pharma Gabapentin Product Market Performance
  10.12.4 Marksans Pharma Business Overview
  10.12.5 Marksans Pharma Recent Developments
10.13 Glenmark
  10.13.1 Glenmark Basic Information
  10.13.2 Glenmark Gabapentin Product Overview
  10.13.3 Glenmark Gabapentin Product Market Performance
  10.13.4 Glenmark Business Overview
  10.13.5 Glenmark Recent Developments
10.14 Alkem
  10.14.1 Alkem Basic Information
  10.14.2 Alkem Gabapentin Product Overview
  10.14.3 Alkem Gabapentin Product Market Performance
  10.14.4 Alkem Business Overview
  10.14.5 Alkem Recent Developments
10.15 Jiangsu Enhua
  10.15.1 Jiangsu Enhua Basic Information
  10.15.2 Jiangsu Enhua Gabapentin Product Overview
  10.15.3 Jiangsu Enhua Gabapentin Product Market Performance
  10.15.4 Jiangsu Enhua Business Overview
  10.15.5 Jiangsu Enhua Recent Developments
10.16 Jiangsu Hengrui
  10.16.1 Jiangsu Hengrui Basic Information
  10.16.2 Jiangsu Hengrui Gabapentin Product Overview
  10.16.3 Jiangsu Hengrui Gabapentin Product Market Performance
  10.16.4 Jiangsu Hengrui Business Overview
  10.16.5 Jiangsu Hengrui Recent Developments
10.17 Sailike
  10.17.1 Sailike Basic Information
  10.17.2 Sailike Gabapentin Product Overview
  10.17.3 Sailike Gabapentin Product Market Performance
  10.17.4 Sailike Business Overview
  10.17.5 Sailike Recent Developments

11 GABAPENTIN MARKET FORECAST BY REGION

11.1 Global Gabapentin Market Size Forecast
11.2 Global Gabapentin Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Gabapentin Market Size Forecast by Country
  11.2.3 Asia Pacific Gabapentin Market Size Forecast by Region
  11.2.4 South America Gabapentin Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Gabapentin by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Gabapentin Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Gabapentin by Type (2026-2033)
  12.1.2 Global Gabapentin Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Gabapentin by Type (2026-2033)
12.2 Global Gabapentin Market Forecast by Application (2026-2033)
  12.2.1 Global Gabapentin Sales (K MT) Forecast by Application
  12.2.2 Global Gabapentin Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS


LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gabapentin Market Size Comparison by Region (M USD)
Table 5. Global Gabapentin Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Gabapentin Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gabapentin Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gabapentin Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin as of 2024)
Table 10. Global Market Gabapentin Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gabapentin Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Gabapentin Sales by Type (K MT)
Table 26. Global Gabapentin Market Size by Type (M USD)
Table 27. Global Gabapentin Sales (K MT) by Type (2020-2025)
Table 28. Global Gabapentin Sales Market Share by Type (2020-2025)
Table 29. Global Gabapentin Market Size (M USD) by Type (2020-2025)
Table 30. Global Gabapentin Market Size Share by Type (2020-2025)
Table 31. Global Gabapentin Price (USD/KG) by Type (2020-2025)
Table 32. Global Gabapentin Sales (K MT) by Application
Table 33. Global Gabapentin Market Size by Application
Table 34. Global Gabapentin Sales by Application (2020-2025) & (K MT)
Table 35. Global Gabapentin Sales Market Share by Application (2020-2025)
Table 36. Global Gabapentin Market Size by Application (2020-2025) & (M USD)
Table 37. Global Gabapentin Market Share by Application (2020-2025)
Table 38. Global Gabapentin Sales Growth Rate by Application (2020-2025)
Table 39. Global Gabapentin Sales by Region (2020-2025) & (K MT)
Table 40. Global Gabapentin Sales Market Share by Region (2020-2025)
Table 41. Global Gabapentin Market Size by Region (2020-2025) & (M USD)
Table 42. Global Gabapentin Market Size Market Share by Region (2020-2025)
Table 43. North America Gabapentin Sales by Country (2020-2025) & (K MT)
Table 44. North America Gabapentin Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Gabapentin Sales by Country (2020-2025) & (K MT)
Table 46. Europe Gabapentin Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Gabapentin Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Gabapentin Market Size by Region (2020-2025) & (M USD)
Table 49. South America Gabapentin Sales by Country (2020-2025) & (K MT)
Table 50. South America Gabapentin Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Gabapentin Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Gabapentin Market Size by Region (2020-2025) & (M USD)
Table 53. Global Gabapentin Production (K MT) by Region(2020-2025)
Table 54. Global Gabapentin Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Gabapentin Revenue Market Share by Region (2020-2025)
Table 56. Global Gabapentin Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Gabapentin Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Gabapentin Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Gabapentin Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Gabapentin Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Pfizer Basic Information
Table 62. Pfizer Gabapentin Product Overview
Table 63. Pfizer Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Pfizer Business Overview
Table 65. Pfizer SWOT Analysis
Table 66. Pfizer Recent Developments
Table 67. Assertio Therapeutics Basic Information
Table 68. Assertio Therapeutics Gabapentin Product Overview
Table 69. Assertio Therapeutics Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Assertio Therapeutics Business Overview
Table 71. Assertio Therapeutics SWOT Analysis
Table 72. Assertio Therapeutics Recent Developments
Table 73. TEVA Basic Information
Table 74. TEVA Gabapentin Product Overview
Table 75. TEVA Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. TEVA Business Overview
Table 77. TEVA SWOT Analysis
Table 78. TEVA Recent Developments
Table 79. Mylan Basic Information
Table 80. Mylan Gabapentin Product Overview
Table 81. Mylan Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Mylan Business Overview
Table 83. Mylan Recent Developments
Table 84. Arbor Pharma Basic Information
Table 85. Arbor Pharma Gabapentin Product Overview
Table 86. Arbor Pharma Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Arbor Pharma Business Overview
Table 88. Arbor Pharma Recent Developments
Table 89. Novartis Basic Information
Table 90. Novartis Gabapentin Product Overview
Table 91. Novartis Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Apotex Basic Information
Table 95. Apotex Gabapentin Product Overview
Table 96. Apotex Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Apotex Business Overview
Table 98. Apotex Recent Developments
Table 99. Sun Pharmaceutical Basic Information
Table 100. Sun Pharmaceutical Gabapentin Product Overview
Table 101. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Sun Pharmaceutical Business Overview
Table 103. Sun Pharmaceutical Recent Developments
Table 104. Aurobindo Pharma Basic Information
Table 105. Aurobindo Pharma Gabapentin Product Overview
Table 106. Aurobindo Pharma Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Aurobindo Pharma Business Overview
Table 108. Aurobindo Pharma Recent Developments
Table 109. Intas Basic Information
Table 110. Intas Gabapentin Product Overview
Table 111. Intas Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Intas Business Overview
Table 113. Intas Recent Developments
Table 114. Amneal Basic Information
Table 115. Amneal Gabapentin Product Overview
Table 116. Amneal Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Amneal Business Overview
Table 118. Amneal Recent Developments
Table 119. Marksans Pharma Basic Information
Table 120. Marksans Pharma Gabapentin Product Overview
Table 121. Marksans Pharma Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Marksans Pharma Business Overview
Table 123. Marksans Pharma Recent Developments
Table 124. Glenmark Basic Information
Table 125. Glenmark Gabapentin Product Overview
Table 126. Glenmark Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Glenmark Business Overview
Table 128. Glenmark Recent Developments
Table 129. Alkem Basic Information
Table 130. Alkem Gabapentin Product Overview
Table 131. Alkem Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Alkem Business Overview
Table 133. Alkem Recent Developments
Table 134. Jiangsu Enhua Basic Information
Table 135. Jiangsu Enhua Gabapentin Product Overview
Table 136. Jiangsu Enhua Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Jiangsu Enhua Business Overview
Table 138. Jiangsu Enhua Recent Developments
Table 139. Jiangsu Hengrui Basic Information
Table 140. Jiangsu Hengrui Gabapentin Product Overview
Table 141. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. Jiangsu Hengrui Business Overview
Table 143. Jiangsu Hengrui Recent Developments
Table 144. Sailike Basic Information
Table 145. Sailike Gabapentin Product Overview
Table 146. Sailike Gabapentin Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Sailike Business Overview
Table 148. Sailike Recent Developments
Table 149. Global Gabapentin Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Global Gabapentin Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Gabapentin Sales Forecast by Country (2026-2033) & (K MT)
Table 152. North America Gabapentin Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Gabapentin Sales Forecast by Country (2026-2033) & (K MT)
Table 154. Europe Gabapentin Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Gabapentin Sales Forecast by Region (2026-2033) & (K MT)
Table 156. Asia Pacific Gabapentin Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Gabapentin Sales Forecast by Country (2026-2033) & (K MT)
Table 158. South America Gabapentin Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Gabapentin Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Gabapentin Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Gabapentin Sales Forecast by Type (2026-2033) & (K MT)
Table 162. Global Gabapentin Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Gabapentin Price Forecast by Type (2026-2033) & (USD/KG)
Table 164. Global Gabapentin Sales (K MT) Forecast by Application (2026-2033)
Table 165. Global Gabapentin Market Size Forecast by Application (2026-2033) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Gabapentin
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gabapentin Market Size (M USD), 2024-2033
Figure 5. Global Gabapentin Market Size (M USD) (2020-2033)
Figure 6. Global Gabapentin Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gabapentin Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gabapentin Product Life Cycle
Figure 13. Gabapentin Sales Share by Manufacturers in 2024
Figure 14. Global Gabapentin Revenue Share by Manufacturers in 2024
Figure 15. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gabapentin Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gabapentin Revenue in 2024
Figure 18. Industry Chain Map of Gabapentin
Figure 19. Global Gabapentin Market PEST Analysis
Figure 20. Global Gabapentin Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gabapentin Market Share by Type
Figure 27. Sales Market Share of Gabapentin by Type (2020-2025)
Figure 28. Sales Market Share of Gabapentin by Type in 2024
Figure 29. Market Size Share of Gabapentin by Type (2020-2025)
Figure 30. Market Size Share of Gabapentin by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gabapentin Market Share by Application
Figure 33. Global Gabapentin Sales Market Share by Application (2020-2025)
Figure 34. Global Gabapentin Sales Market Share by Application in 2024
Figure 35. Global Gabapentin Market Share by Application (2020-2025)
Figure 36. Global Gabapentin Market Share by Application in 2024
Figure 37. Global Gabapentin Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gabapentin Sales Market Share by Region (2020-2025)
Figure 39. Global Gabapentin Market Size Market Share by Region (2020-2025)
Figure 40. North America Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gabapentin Sales Market Share by Country in 2024
Figure 43. North America Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gabapentin Market Size Market Share by Country in 2024
Figure 45. U.S. Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gabapentin Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gabapentin Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gabapentin Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gabapentin Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gabapentin Sales Market Share by Country in 2024
Figure 53. Europe Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gabapentin Market Size Market Share by Country in 2024
Figure 55. Germany Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gabapentin Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gabapentin Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gabapentin Market Size Market Share by Region in 2024
Figure 68. China Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gabapentin Sales and Growth Rate (K MT)
Figure 79. South America Gabapentin Sales Market Share by Country in 2024
Figure 80. South America Gabapentin Market Size and Growth Rate (M USD)
Figure 81. South America Gabapentin Market Size Market Share by Country in 2024
Figure 82. Brazil Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gabapentin Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gabapentin Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gabapentin Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gabapentin Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gabapentin Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gabapentin Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gabapentin Production Market Share by Region (2020-2025)
Figure 103. North America Gabapentin Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gabapentin Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gabapentin Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gabapentin Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gabapentin Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Gabapentin Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gabapentin Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gabapentin Market Share Forecast by Type (2026-2033)
Figure 111. Global Gabapentin Sales Forecast by Application (2026-2033)
Figure 112. Global Gabapentin Market Share Forecast by Application (2026-2033)


More Publications